James Gregory Ford
Amministratore Delegato presso Metuchen Pharmaceuticals LLC
Profilo
James Gregory Ford currently works at Metuchen Pharmaceuticals LLC, as President & Chief Executive Officer.
Mr. Ford also formerly worked at Petros Pharmaceuticals, Inc., as Chief Executive Officer, Boehringer Ingelheim Pharmaceuticals, Inc., as Associate Director-Business Development from 1997 to 1999, CollaGenex Pharmaceuticals, Inc., as VP-Business Development & Strategic Planning from 2004 to 2008, PolyMedix, Inc., as Vice President-Business Development, SkyePharma Canada, Inc., as President & Chief Operating Officer from 1999 to 2004, and Pacira Pharmaceuticals, Inc. (California), as Vice President-Global Business Development.
Mr. Ford received his undergraduate degree and Masters Business Admin degree from West Virginia University.
Posizioni attive di James Gregory Ford
| Società | Posizione | Inizio |
|---|---|---|
Metuchen Pharmaceuticals LLC
 Metuchen Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Metuchen Pharmaceuticals LLC operates as a pharmaceuticals company. It develops, markets, sells and distributes Stendra drug. The company was foundeded in 2016 and is headquartered in Cranford, NJ. | Amministratore Delegato | - |
Precedenti posizioni note di James Gregory Ford
| Società | Posizione | Fine |
|---|---|---|
| PETROS PHARMACEUTICALS | Amministratore Delegato | 04/07/2020 |
CollaGenex Pharmaceuticals, Inc.
 CollaGenex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology CollaGenex Pharmaceuticals, Inc. develops and markets innovative medical therapies to the dental and dermatology market. The company was founded in 1992 and is headquartered in Newtown, PA. | Corporate Officer/Principal | 10/04/2008 |
Pacira Pharmaceuticals, Inc. (California)
 Pacira Pharmaceuticals, Inc. (California) Medical SpecialtiesHealth Technology Pacira Pharmaceuticals, Inc. develops and manufactures injectable and sustained release therapeutic products. It focuses on clinical and commercial development activities by understanding the needs of the acute care market. The company was founded in March 2007 and is headquartered in San Diego, CA. | Corporate Officer/Principal | - |
SkyePharma Canada, Inc.
 SkyePharma Canada, Inc. Miscellaneous Commercial ServicesCommercial Services SkyePharma Canada, Inc. improves the solubility of drugs through the use of nano-particulate technology. The company is based in Verdun, Canada. SkyePharma Canada was acquired by SkyePharma Plc on March 13, 2002 for $20.01 million. | Presidente | 01/01/2004 |
Boehringer Ingelheim Pharmaceuticals, Inc.
 Boehringer Ingelheim Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim Pharmaceuticals, Inc. manufactures pharmaceuticals products. It develops and markets drugs for the treatment of respiratory, cancer, cardiovascular, immunological and central nervous system diseases. The company was founded in 1971 and is headquartered in Ridgefield, CT. | Corporate Officer/Principal | 01/01/1999 |
Formazione di James Gregory Ford
| West Virginia University | Masters Business Admin |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| PETROS PHARMACEUTICALS | Health Technology |
| Aziende private | 6 |
|---|---|
CollaGenex Pharmaceuticals, Inc.
CollaGenex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology CollaGenex Pharmaceuticals, Inc. develops and markets innovative medical therapies to the dental and dermatology market. The company was founded in 1992 and is headquartered in Newtown, PA. | Health Technology |
PolyMedix, Inc.
 PolyMedix, Inc. Pharmaceuticals: MajorHealth Technology PolyMedix, Inc. engaged in developing first-in-class, small-molecule defensin-mimetics for the treatment of serious acute care conditions. The company was founded in 2002 and was headquartered in Radnor, PA. | Health Technology |
SkyePharma Canada, Inc.
SkyePharma Canada, Inc. Miscellaneous Commercial ServicesCommercial Services SkyePharma Canada, Inc. improves the solubility of drugs through the use of nano-particulate technology. The company is based in Verdun, Canada. SkyePharma Canada was acquired by SkyePharma Plc on March 13, 2002 for $20.01 million. | Commercial Services |
Pacira Pharmaceuticals, Inc. (California)
Pacira Pharmaceuticals, Inc. (California) Medical SpecialtiesHealth Technology Pacira Pharmaceuticals, Inc. develops and manufactures injectable and sustained release therapeutic products. It focuses on clinical and commercial development activities by understanding the needs of the acute care market. The company was founded in March 2007 and is headquartered in San Diego, CA. | Health Technology |
Boehringer Ingelheim Pharmaceuticals, Inc.
Boehringer Ingelheim Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim Pharmaceuticals, Inc. manufactures pharmaceuticals products. It develops and markets drugs for the treatment of respiratory, cancer, cardiovascular, immunological and central nervous system diseases. The company was founded in 1971 and is headquartered in Ridgefield, CT. | Health Technology |
Metuchen Pharmaceuticals LLC
Metuchen Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Metuchen Pharmaceuticals LLC operates as a pharmaceuticals company. It develops, markets, sells and distributes Stendra drug. The company was foundeded in 2016 and is headquartered in Cranford, NJ. | Health Technology |
- Borsa valori
- Insiders
- James Gregory Ford
